235 related articles for article (PubMed ID: 15754032)
1. Expression of hTERT mRNA in a mortal liver cell line during S phase without detectable telomerase activity.
Nagao K; Ohyashiki JH; Ohyashiki K; Tabata K; Takai K; Kameyama K; Kitano S; Kawano K; Hibi N; Kanamaru T; Hisatomi H
Int J Mol Med; 2005 Apr; 15(4):683-8. PubMed ID: 15754032
[TBL] [Abstract][Full Text] [Related]
2. Telomerase activity in human hepatocellular carcinoma: parallel correlation with human telomerase reverse transcriptase (hTERT) mRNA isoform expression but not with cell cycle modulators or c-Myc expression.
Chen CJ; Tsai NM; Liu YC; Ho LI; Hsieh HF; Yen CY; Harn HJ
Eur J Surg Oncol; 2002 Apr; 28(3):225-34. PubMed ID: 11944954
[TBL] [Abstract][Full Text] [Related]
3. [Preliminary study on the alternative splicing pattern of human telomerase reverse transcriptase gene during gastric carcinogenesis].
Wang YC; Xu JH; Geng X; Zhang WM
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2009 Apr; 26(2):151-5. PubMed ID: 19350505
[TBL] [Abstract][Full Text] [Related]
4. Expression and alternative splicing pattern of human telomerase reverse transcriptase in human lung cancer cells.
Fujiwara M; Kamma H; Wu W; Hamasaki M; Kaneko S; Horiguchi H; Matsui-Horiguchi M; Satoh H
Int J Oncol; 2004 Apr; 24(4):925-30. PubMed ID: 15010831
[TBL] [Abstract][Full Text] [Related]
5. Expression of human telomerase reverse transcriptase splice variants is well correlated with low telomerase activity in osteosarcoma cell lines.
Fujiwara-Akita H; Maesawa C; Honda T; Kobayashi S; Masuda T
Int J Oncol; 2005 Apr; 26(4):1009-16. PubMed ID: 15753996
[TBL] [Abstract][Full Text] [Related]
6. [Changes of alternative splicing variants of human telomerase reverse transcriptase during gastric carcinogenesis].
Xu JH; Wang YC; Geng X; Zhang WM
Ai Zheng; 2008 Dec; 27(12):1271-6. PubMed ID: 19079992
[TBL] [Abstract][Full Text] [Related]
7. Characterization of novel alternative splicing sites in human telomerase reverse transcriptase (hTERT): analysis of expression and mutual correlation in mRNA isoforms from normal and tumour tissues.
Saebøe-Larssen S; Fossberg E; Gaudernack G
BMC Mol Biol; 2006 Aug; 7():26. PubMed ID: 16939641
[TBL] [Abstract][Full Text] [Related]
8. Lack of telomerase activity in lung carcinoids is dependent on human telomerase reverse transcriptase transcription and alternative splicing and is associated with long telomeres.
Zaffaroni N; Villa R; Pastorino U; Cirincione R; Incarbone M; Alloisio M; Curto M; Pilotti S; Daidone MG
Clin Cancer Res; 2005 Apr; 11(8):2832-9. PubMed ID: 15837730
[TBL] [Abstract][Full Text] [Related]
9. Telomerase activity in human development is regulated by human telomerase reverse transcriptase (hTERT) transcription and by alternate splicing of hTERT transcripts.
Ulaner GA; Hu JF; Vu TH; Giudice LC; Hoffman AR
Cancer Res; 1998 Sep; 58(18):4168-72. PubMed ID: 9751630
[TBL] [Abstract][Full Text] [Related]
10. [Effect of telomerase on ginsenoside Rh2-induced differentiation of hepatocarcinoma cell line SMMC-7721].
Zeng XL; Tu ZG
Ai Zheng; 2004 Dec; 23(12):1655-9. PubMed ID: 15601555
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of full-length telomerase reverse transcriptase mRNA and telomerase activity between normal and malignant renal tissues.
Fan Y; Liu Z; Fang X; Ge Z; Ge N; Jia Y; Sun P; Lou F; Björkholm M; Gruber A; Ekman P; Xu D
Clin Cancer Res; 2005 Jun; 11(12):4331-7. PubMed ID: 15958614
[TBL] [Abstract][Full Text] [Related]
12. [Inhibitory effect of antisense human telomerase reverse transcriptase(hTERT) on telomerase activity of human pulmonary giant cell carcinoma cell line(PLA-801D)].
Ma XB; Han WD; Hao HJ; Li Q; Xu ZM; Lu XC; Zhao YL
Ai Zheng; 2003 Sep; 22(9):932-7. PubMed ID: 12969524
[TBL] [Abstract][Full Text] [Related]
13. Differential alternative splicing expressions of telomerase reverse transcriptase in gastrointestinal cell lines.
Nagao K; Katsumata K; Aizawa Y; Saito N; Hirata H; Sasaki H; Yamamoto S; Hikiji K; Koiwa T; Hisatomi H
Oncol Rep; 2004 Jan; 11(1):127-31. PubMed ID: 14654914
[TBL] [Abstract][Full Text] [Related]
14. Transcription and alternative splicing of telomerase reverse transcriptase in benign and malignant breast tumours and in adjacent mammary glandular tissues: implications for telomerase activity.
Zaffaroni N; Della Porta C; Villa R; Botti C; Buglioni S; Mottolese M; Grazia Daidone M
J Pathol; 2002 Sep; 198(1):37-46. PubMed ID: 12210061
[TBL] [Abstract][Full Text] [Related]
15. Telomerase activity and expression of telomerase genes in squamous dysplasia and squamous cell carcinoma of the esophagus.
Yu HP; Xu SQ; Lu WH; Li YY; Li F; Wang XL; Su YH
J Surg Oncol; 2004 May; 86(2):99-104. PubMed ID: 15112252
[TBL] [Abstract][Full Text] [Related]
16. Human normal T lymphocytes and lymphoid cell lines do express alternative splicing variants of human telomerase reverse transcriptase (hTERT) mRNA.
Jalink M; Ge Z; Liu C; Björkholm M; Gruber A; Xu D
Biochem Biophys Res Commun; 2007 Feb; 353(4):999-1003. PubMed ID: 17204238
[TBL] [Abstract][Full Text] [Related]
17. Antisense human telomerase reverse transcriptase could partially reverse malignant phenotypes of gastric carcinoma cell line in vitro.
Yang SM; Fang DC; Yang JL; Chen L; Luo YH; Liang GP
Eur J Cancer Prev; 2008 Jun; 17(3):209-17. PubMed ID: 18414191
[TBL] [Abstract][Full Text] [Related]
18. Role of human T-cell leukemia virus type I Tax in expression of the human telomerase reverse transcriptase (hTERT) gene in human T-cells.
Hara T; Matsumura-Arioka Y; Ohtani K; Nakamura M
Cancer Sci; 2008 Jun; 99(6):1155-63. PubMed ID: 18422743
[TBL] [Abstract][Full Text] [Related]
19. Changes of the alternative splicing variants of human telomerase reverse transcriptase during gastric carcinogenesis.
Xu JH; Wang YC; Geng X; Li YY; Zhang WM
Pathobiology; 2009; 76(1):23-9. PubMed ID: 19188747
[TBL] [Abstract][Full Text] [Related]
20. Lack of telomerase gene expression in alternative lengthening of telomere cells is associated with chromatin remodeling of the hTR and hTERT gene promoters.
Atkinson SP; Hoare SF; Glasspool RM; Keith WN
Cancer Res; 2005 Sep; 65(17):7585-90. PubMed ID: 16140922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]